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Abstract 
 
Objective 
Schizophrenia may be the result of a failure of the normal lateralization process of the brain. However, 
whole-brain asymmetry has not been assessed up to date. Here we propose a novel measure of global 
brain asymmetry based on the Dice coefficient in order to quantify similarity between brain 
hemispheres. 
 
Method 
Global gray and white matter asymmetry was calculated from high-resolution T1 structural images 
acquired from 24 patients with schizophrenia and 26 healthy controls, age- and sex-matched. Some of 
the analyses were replicated in a much larger sample (n = 759) obtained from open-access online 
databases. 
 
Results 
Patients with schizophrenia had more global gray matter asymmetry than controls. Additionally, 
increased gray matter asymmetry was associated with avolition, whereas the inverse relationship was 
found for anxiety. These analyses were replicated in a larger sample and confirmed previous results. 
 
Conclusion 
Our findings suggest that global gray matter asymmetry is related to the concept of developmental 
stability and is a useful indicator of perturbations during neurodevelopment. 
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Significant outcomes 
- Global gray matter is more asymmetric in patients with schizophrenia than in controls. This finding was 
replicated in large and independent samples. 
- Avolition and anxiety are associated with global gray matter asymmetry in patients. 
- Global gray matter asymmetry may be an indicator of early developmental perturbations. 
 
Limitations 
- Information on verbal IQ and education level could not be analyzed in Study II. 
- Scores of anxiety symptoms were not available for participants of Study II. 
- The potential effects of the psychiatric medication could not be analyzed. 
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Introduction 
The concept of developmental stability (DS) refers to the capacity of an organism to buffer its 
development against genetic or environmental perturbations. The most common measure to estimate 
DS is fluctuating asymmetry (FA), which assumes that the development of the two sides of a symmetric 
organism is influenced by the same genes. Therefore, any difference between the two sides is assumed 
to be a consequence of a genetic or environmental perturbation, thus reflecting the DS efficiency of the 
organism [1]. FA aims to quantify the left-right asymmetry degree, and accounts for the slight random 
variations present in the organism [2], rather than for systematic asymmetry variations. However, this 
measure has been commonly employed in the body, e.g. by measuring the length of the fingers of both 
hands [3], but it has not been used to quantify the degree of asymmetry between brain hemispheres. 
Rather, research on brain asymmetries has focused mainly on the systematic structural asymmetries 
that exist between left and right hemispheres [2]. Some brain functions, such as language and spatial 
attention, have been shown to be lateralized. Moreover, lateralization of functions seems to be 
associated with structural changes [4, 5]. Hemispheric dominance derived from these brain asymmetries 
may have some evolutionary advantages, such as greater processing speed, as a consequence of not 
having to rely on communication between the two hemispheres, and the avoidance of duplicated 
functions and redundant neural circuits [2]. 
 
Brain asymmetries have received a good deal of attention in schizophrenia. Crow et al. [6] considered 
schizophrenia to be the result of a failure in the normal brain lateralization process. A review by Oertel-
Knöchel and Linden [7] showed that, in fact, a reduced degree of cerebral asymmetry in localized 
regions is often associated with schizophrenia, e.g., patients seem to have reduced structural 
asymmetry in the temporal lobe, and the normal cerebral torque is reduced or absent. A meta-analysis 
concluded that the process of cortical gray matter volume loss in patients with schizophrenia was more 
active in the left than in the right hemisphere, which could explain the abnormal asymmetries seen in 
these patients [8]. Reduced white matter asymmetry in localized regions has also been found in 
schizophrenia, which has been attributed to neurodevelopmental abnormalities [9]. Furthermore, a 
meta-analysis of dichotic listening studies concluded that reduced language lateralization was 
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particularly marked in those patients with schizophrenia suffering from auditory hallucinations [10]. 
Additionally, the degree of reduced lateralization of the temporal lobe seems to be positively correlated 
with severity of hallucinations and other positive symptoms [7, 11]. Differences in the left-right sulcal 
asymmetry between patients with and without visual hallucinations have also been found [12]. Studies 
examining potential associations between cerebral asymmetry and negative or affective symptoms are 
scarce, although these symptoms have been shown to have important clinical [13] and cognitive [14, 15] 
effects in schizophrenia. Even though results are inconclusive, it seems that both negative symptoms 
and depression are associated with loss of asymmetry [16, 17]. 
 
To our knowledge, all of the studies published to date regarding cerebral asymmetry and schizophrenia 
have focused on the characterization of specific brain regions known to present abnormal degrees of 
symmetry. A global measure of asymmetry between the left and right hemispheres, which could provide 
additional information about neurodevelopment and which might be related to the concept of 
developmental stability, has yet to be tested. In order to compare global gray and white matter 
asymmetry between patients with schizophrenia and healthy controls, we developed a novel approach 
of global asymmetry that accumulates all the local asymmetries found in the brain and which may 
account for the random variations of it, rather than for the systematic variations. This measure is based 
on the Dice coefficient [18] and has not been used previously in this kind of study. 
 
 Aims of the study 
Here we present two studies in which we employ this new measure. In Study I, we compare global gray 
and white matter asymmetry, with the measure based on the Dice coefficient, between patients with 
schizophrenia and healthy controls. In addition, we will also evaluate whether hallucinations, delusions, 
negative symptoms, and/or affective symptoms are associated with global brain asymmetry in patients 
with schizophrenia. Given the lack of literature assessing brain asymmetries with a global approach, 
these analyses are exploratory. In Study II, we will try to replicate results from Study I, employing the 
same methodology as in Study I with a larger sample of patients with schizophrenia and healthy controls 
obtained from several open-access databases. 
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STUDY I 
1. Methods 
 1.1. Participants 
A total of 50 participants, 24 patients with schizophrenia and 26 age- and sex-matched healthy control 
participants, were included in Study I, which is part of a broader reality-monitoring study. This study was 
approved by the Ethics Committee of Fundació Sant Joan de Déu. Patients were recruited from the Parc 
Sanitari Sant Joan de Déu network of mental health services in Barcelona, Spain. Inclusion criteria for 
patients were age between 18 and 60 years, native fluency in Spanish, and the ability to provide 
informed consent. Exclusion criteria for patients were having an organic mental disorder, dementia, 
intellectual disability, head injury, alcohol or other drug abuse in the past 6 months, current severe 
physical disease, and the standard exclusion criteria for participation in neuroimaging procedures, i.e., 
claustrophobia and metallic implants. Healthy control participants were recruited from the general 
population by advertisements in the public access areas of the hospital campus. Inclusion criteria for 
healthy control participants were age between 18 and 60 years and native fluency in Spanish. Exclusion 
criteria for healthy control participants were having a neurological or mental disease, intellectual 
disability, head injury, alcohol or other drug abuse in the past 6 months, current severe physical disease, 
and the standard exclusion criteria for participating in neuroimaging procedures. Comparison was made 
of sociodemographic and clinical data between patients with schizophrenia and healthy control 
participants from Study I by means of a T-test for independent samples. Differences in sex distribution 
were analyzed with a chi-square test. This information is presented in the Supplementary Table 1. As 
expected, there were no significant differences in age or sex distribution. However, healthy controls 
were significantly better educated and scored higher in verbal IQ than patients. Verbal IQ was assessed 
with the Test de Acentuación de Palabras (TAP) [19] vocabulary test, a Spanish equivalent of the 
National Adult Reading Test (NART). 
 
 1.2. Clinical evaluation 
Positive, negative, and affective symptoms (depression and anxiety) were assessed in patients by means 
of the following scales: 
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- Positive symptoms: the Spanish version of the Scale for the Assessment of Positive Symptoms (SAPS) 
was used. Scores on the hallucinations and delusions subscales were used for the analyses. 
 
- Negative symptoms: the Spanish version of the Scale for the Assessment of Negative Symptoms (SANS) 
was used. Since attention disorders are considered as different from negative symptomatology, the 
attention items were discarded. The items of the other four categories (flat affect, alogia, avolition, and 
anhedonia) were added together to constitute SANS-4, the negative symptoms score considered in the 
analyses. 
 
- Affective symptoms: depression scores were obtained by means of the Calgary Depression Scale, 
whereas anxiety scores were obtained by means of the Hamilton Anxiety Rating Scale. 
 
Clinical evaluation was conducted after the completion of the neuroimaging procedure by an 
experienced clinical psychologist trained in the administration of all these scales. 
 
 1.3. Data acquisition 
MRI data were acquired using a General Electric 1.5 Tesla Signa HDe scanner at Parc Sanitari Sant Joan 
de Déu. For each participant, a high-resolution T1-weighted FSPGR structural image with the axial plane 
parallel to the AC-PC axis was acquired using the following parameters: 2 mm slice thickness, TR = 12.24 
ms, TE = 3.84 ms, FOV = 24 cm, acquisition matrix = 512 × 512, flip angle = 20°, voxel size = 0.47 × 0.47 × 
2.00 mm3. The protocol included the acquisition of other experimental images not used in the present 
study. 
 
 1.4. Data processing 
Neuroimaging data were analyzed with SPM8 (Wellcome Department of Imaging Neuroscience, London; 
www.fil.ion.ucl.ac.uk/spm) running under MATLAB (Release 2009a, The MathWorks, Inc., Natick, 
Massachusetts), following an adaptation of a recently published protocol to analyze gray matter 
asymmetries [20].First of all, gray matter and white matter were segmented for all the participants. 
These gray and white matter segments were then flipped, i.e., a new image was created with the left 
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and right hemispheres reversed. This process allowed the creation of a symmetric DARTEL anatomical 
template from the original and flipped gray and white matter segments of all the participants. Finally, 
the original and flipped gray and white matter segments for each participant were registered to the 
newly created symmetric DARTEL template in order to align the brains of all the participants in a 
common space. Aiming to prevent volume changes as a consequence of the registration process, the 
gray and white matter segments were modulated, as suggested by Kurth et al. [20] 
 
 1.5. Data analysis 
Once the modulated gray and white matter segments were warped into the symmetric DARTEL 
template, the Dice coefficient of the modulated original and flipped images (i.e., between left and right 
hemispheres) was calculated for each participant. The Dice coefficient was originally used in ecology to 
quantify the degree of association between different species [18], and it has also been employed in MRI 
studies to validate the quality of image segmentation [21]. The Dice coefficient was obtained according 
to the following formula: 
 |⋂||||| , 
 
in which, in our case, i1 and i2 are the images containing the original and flipped gray or white matter 
segments, respectively, and i1int and i2int are the total intensity values for each image. The intersection 
for each voxel was considered as the minimum intensity value between the two images. This was later 
multiplied by 2 and divided by the sum of the total intensities of the two images. The 'nii_dice.m' 
MATLAB script (https://github.com/neurolabusc) was used to automatically calculate the Dice 
coefficient. The resulting Dice score was used as a measure of global brain asymmetry. The Dice 
coefficient score ranges from 0 to 1, with higher values indicating a lower degree of asymmetry. A 
graphical representation of the Dice coefficient is depicted in Figure 1. In addition, the total volume of 
each hemisphere was computed for each participant. The left/right hemisphere volume ratio was then 
obtained by dividing the volume of the left hemisphere over the volume of the right hemisphere. 
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 1.6. Statistical analysis 
First, in order to be certain that the potential significant results from asymmetry analyses were not due 
to uneven volume loss between hemispheres [8], the left/right hemisphere volume ratio was compared 
between patients with schizophrenia and healthy control participants by means of an ANCOVA, with 
diagnostic group (patients or controls) as the between-subject factor, and verbal IQ score and education 
level as covariates. Second, a comparison of global gray and white matter asymmetry between patients 
with schizophrenia and healthy controls was made by means of an ANCOVA conducted for the Dice 
scores, with diagnostic group as the between-subject factor, and verbal IQ score and education level as 
covariates. After that, aiming to determine which clinical variables were associated with global gray or 
white matter asymmetry, a backward elimination regression analysis was performed on the gray and 
white matter Dice scores of the patients. The following clinical variables were tested and included as 
predictors in the analysis: hallucinations, delusions, SANS-4, depression, and anxiety. Furthermore, the 
following sociodemographic variables were also included as predictors in the analysis to account for 
potential confounding factors: age, sex, education, verbal IQ, and years of duration of the illness. 
Afterwards, the schizophrenia sample was divided in accordance with the variables that were 
significantly associated with the gray or white matter Dice score in the backward elimination analysis 
previously performed. These subsamples of patients with or without the symptom of interest were also 
compared to the healthy control participants with further ANCOVA conducted for the Dice scores, with 
diagnostic group as the between-subject factor. Verbal IQ score and/or education level were included as 
covariates when they were significantly different between the corresponding subsample of patients and 
the healthy controls, since they could have an impact on gray and white matter [22]. Clinical variables 
were normalized by square root normalization when required. 
 
2. Results 
 2.1. Group comparison in cerebral asymmetry 
Left/right hemisphere gray matter volume ratio was not different between patients with schizophrenia 
and healthy control participants (p = .418). The ANCOVA controlling for verbal IQ and education level 
showed that patients with schizophrenia had more asymmetric global gray matter than the healthy 
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controls [F(1, 46) = 4.361, p = .042, η2 = .069] (Table 1 and Figure 2). No differences were seen when 
analyzing global white matter asymmetry (p = .874). 
 
 2.2. Cerebral asymmetry and clinical symptoms in schizophrenia 
Backward elimination regression analyses were carried out in order to assess which clinical variables 
were associated with gray or white matter global asymmetry. Only anxiety (β = .618, p = .020) was found 
to be significantly positively correlated with the gray matter Dice score, while SANS-4 (β = -.655, p = 
.015) was significantly negatively correlated with the gray matter Dice score. No associations between 
global gray matter asymmetry and hallucinations, delusions, depression or the sociodemographic 
variables were found either. In addition, none of the clinical and sociodemographic variables analyzed 
were associated with the white matter Dice score. Given the significant association found between 
SANS-4 and gray matter global asymmetry, another backward elimination regression analysis on the 
gray matter Dice scores was carried out to determine which of the negative symptoms were responsible 
for this association. In this case, each of the four negative symptoms, as well as anxiety, were included 
as predictors. This analysis yielded a model (F(2, 21) = 6.65, p = .006; R2 = 0.39) in which avolition was 
significantly negatively associated with the gray matter Dice score (β = -.735, p = .002) while the 
previous positive association between anxiety and the gray matter Dice score was maintained (β = .619, 
p = .008). No significant associations arose for the rest of the negative symptoms. Further analyses 
separating by patients presenting those symptoms or not were carried out. Patients were separated into 
low anxiety (n = 12) or high anxiety (n = 12) according to the median score (M = 5.5, IQR = 8.5) of all the 
patients in the Hamilton Anxiety Rating Scale. In the case of avolition, patients were considered not to 
have avolition if they scored 0 points in the avolition item (n = 17); otherwise they were considered to 
have avolition (n = 7). The analyses conducted on anxiety revealed that patients with low scores of 
anxiety were more asymmetric than the healthy controls, with a trend towards significance (p = .059, η2 
= .087), whereas there were no differences in symmetry between patients with high scores of anxiety 
and controls (p = .171, η2 = .051). Conversely, analyses separating by patients with or without avolition 
showed that patients with avolition were significantly more asymmetric than the healthy controls (p = 
.001, η2 = .296), whereas patients without avolition did not differ from healthy controls in global 
asymmetry (p = .226, η2 = .026). These results are displayed in Table 1 and depicted in Figure 2. 
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STUDY II 
1. Methods 
 1.1. Participants 
A total of 759 participants, 355 patients with schizophrenia and 404 healthy controls, were included in 
Study II. Data from these participants were obtained from four open-access databases available for 
download from schizconnect.org and openfmri.org. Specifically, the data used were obtained from the 
'NU Schizophrenia Data and Software Tool (NUSDAST)', the 'Mind Clinical Imaging Consortium (MCIC)' 
[23], and the 'Center of Biomedical Research Excellence (COBRE)' [24] databases available at 
schizconnect.org, as well as from the database with accession number 'ds000115' [25] at openfmri.org. 
High-resolution T1 images were also available from these databases. The age range of the group of 
patients with schizophrenia went from 16 to 65, whereas in the group of healthy control participants 
went from 12 to 67. Age and sex distribution were compared between patients with schizophrenia and 
healthy control participants by means of a T-test for independent samples and a chi-square test, 
respectively. These analyses showed that patients with schizophrenia were significantly older (patients = 
34.68 ± 12.46 years old; controls = 31.48 ± 13.08 years old, p < .001) and included a significantly larger 
proportion of males (patients = 73% of males; controls = 59% of males, p < .001). Neither verbal IQ nor 
education could be compared between patients and controls as their assessment was different between 
studies and it was not possible to establish an equivalence of the scores. 
 
 1.2. Clinical variables 
Of the two variables that were significantly associated with gray matter asymmetry in Study I, avolition 
and anxiety, only avolition scores were available for all the participants. Avolition was assessed by 
means of either the item 17 ('Global rating of avolition-apathy') of the Scale for the Assessment of 
Negative Symptoms (SANS) or the item G13 ('Disturbance of volition') of the Positive and Negative 
Syndrome Scale (PANSS). Participants were divided into three groups according to their avolition scores. 
Hence, those participants scoring 0 (absent) or 1 (questionable/minimal) were considered as part of the 
group of 'No avolition' (n = 142); those scoring 2 (mild) or 3 (moderate) were considered as part of the 
'low avolition' group (n = 156); and finally, those participants scoring from 4 (marked/moderate severe) 
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to 5 (severe) or 6 (extreme, only in the PANSS) were considered as part of the 'high avolition' group (n = 
57). 
 
 1.3. Data processing and analysis 
All the neuroimaging data were processed and analyzed, independently for each database, exactly as 
described in sections 1.4 and 1.5 of Study I. 
 
 1.4. Statistical analysis 
First, in order to ascertain that the potential significant results from asymmetry analyses were not due 
to uneven volume loss between hemispheres, the left/right hemisphere volume ratio was compared 
between patients with schizophrenia and healthy control participants by means of an ANCOVA, with 
diagnostic group (patients or controls) as the between-subject factor, and age, sex, and database 
number as covariates. Second, a comparison of global gray and white matter asymmetry between 
patients with schizophrenia and healthy controls was performed by means of an ANCOVA conducted for 
the Dice scores, with diagnostic group as the between-subject factor, and age, sex, and database 
number as covariates. After that, another ANCOVA was performed among the patients with 
schizophrenia, with avolition (three categories, see above) as the between-subject factor and the gray 
and white matter Dice scores as the dependent variable. Age and database number were included as 
covariates. Sex was not included as covariate since its distribution was not different among the three 
avolition categories. Overall, age and sex were included as covariates, when they differed between 
groups, because they could have an impact on brain asymmetry [26]. Database number was always 
included as a covariate to control for potential differences due to the scanner used to acquire structural 
images. 
 
2. Results 
 2.1. Group comparison in cerebral asymmetry 
Left/right hemisphere gray matter volume ratio was not different between patients with schizophrenia 
and healthy control participants (p = .336). The ANCOVA controlling for age, sex, and database number 
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confirmed results seen in Study I, i.e., patients with schizophrenia had more asymmetric global gray 
matter than the healthy controls [F(1, 754) = 13.790, p < .001, η2 = .012] (Figure 3). This difference was 
not seen when analyzing global white matter asymmetry (p = .584). Interestingly, age (p < .001, η2 = 
.235) and sex (p < .001, η2 = .063) were also importantly associated with global gray matter asymmetry. 
A graphical representation of the asymmetry differences between patients with schizophrenia and 
healthy control participants is depicted in Figure 4.  
 
 2.2. Cerebral asymmetry and avolition in schizophrenia 
Patients were separated into three categories according to their score in avolition. An ANCOVA 
controlling for age and number of study showed an association between avolition and global gray 
matter asymmetry [F(2, 350) = 4.001, p = .019, η2 = .016. A post-hoc analysis revealed that the 'high 
avolition' group had significantly more global gray matter asymmetry than the 'no avolition' group (p = 
.018) and the 'low avolition' group (p = .050). On the other hand, no differences were seen between the 
'low avolition' and the 'no avolition' groups (Figure 3). All the avolition groups, however, had 
significantly more global gray matter asymmetry than the group of healthy controls ('no avolition', p = 
.004; 'low avolition', p = .003; 'high avolition', p < .001). As was expected from the results of Study I, 
there was no association between avolition and global white matter asymmetry. 
 
Discussion 
This is the first study to compare global brain asymmetry, by means of the Dice coefficient, of patients 
with schizophrenia and healthy control participants, and also the first to look for potential associations 
between global brain asymmetry and clinical symptomatology in patients with schizophrenia. Our main 
findings show that patients with schizophrenia have more globally asymmetric gray matter than healthy 
control participants. With respect to clinical symptoms in patients with schizophrenia, anxiety and 
avolition were associated with global gray matter asymmetry, while other symptoms, including 
hallucinations, were not. 
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Global gray matter was found to be more asymmetric in patients with schizophrenia than in healthy 
controls, whereas no differences were seen for global white matter asymmetry. This is in contrast to 
studies assessing specific local brain asymmetries, with most of them reporting that patients with 
schizophrenia had reduced structural asymmetry in certain brain regions when compared with the 
general population (for a review, see Oertel-Knöchel and Linden [7]). However, we have to consider 
global cerebral asymmetry and regional cerebral asymmetry as different things. Indeed, while 
lateralization of some brain functions may provide an evolutionary advantage [2] and the lack of 
lateralization could be an indicator of  an abnormal development of the brain, this assumption should 
not be generalized when considering the brain as a whole. In this sense, there are a number of reasons 
to consider that, aside from the normal lateralization process, the brain is expected to develop 
symmetrically. One of these is that most brain structures are found symmetrically in the two 
hemispheres. In addition, since the brain is largely devoted to communicating, through motor and 
sensory systems, with the body, which is almost perfectly symmetric in the left-right plane, it is 
reasonable to think that preserving this symmetry in the brain would have an intrinsic evolutionary 
advantage. Hence, a high degree of global cerebral asymmetry may also be an indicator of abnormal 
brain development. This supposition could be linked with the concept of developmental stability. 
Indeed, Euler et al. [27] found that patients with schizophrenia had lower DS than healthy controls, i.e., 
had presumably more perturbations during development. The degree of DS was assessed by means of a 
measure of body FA, and their results provide additional evidence for the link between schizophrenia 
and developmental perturbations. Therefore, quantifying global gray matter asymmetry, by means of 
the Dice coefficient, could be a good measure of FA and a reflection of early neurodevelopmental 
problems. Compared with body FA measures, quantifying global gray matter asymmetry has the 
advantage of being a more direct and objective measure of neurodevelopment, and one that is less 
exposed to physical disturbances, making it potentially more reliable. In addition, this finding cannot be 
explained by a larger loss of volume in the left hemisphere as compared with the right hemisphere, as 
suggested in the meta-analysis of Vita et al. [8], since the left/right hemisphere volume ratio was not 
different between patients with schizophrenia and healthy control participants. 
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A graphical representation of gray matter asymmetry differences between patients with schizophrenia 
and healthy control participants allowed us to verify that the distribution of these differences was broad 
and present all over the brain, thus confirming the relevance of considering global brain asymmetry. As 
expected, larger regions of the brain were more symmetric in healthy control participants than in 
patients with schizophrenia, although the latter showed some regions in which they were more 
symmetric. Particularly, it is important to emphasize that the prefrontal region, the thalamus, and the 
insula were markedly more symmetric in healthy control participants than in patients with 
schizophrenia. These regions have been deemed as being important in the psychopathology of 
schizophrenia [28-30]. Conversely, the caudate nucleus was more symmetric in patients with 
schizophrenia than in healthy control participants. In this sense, abnormalities related to schizophrenia 
in the functional lateralization of the caudate nucleus have been already reported [31]. 
 
We also explored the potential associations between global gray or white matter asymmetry and clinical 
symptoms. No such association arose for delusions, depression, or, most importantly, hallucinations. 
Although some previous studies found a relationship between asymmetry or lateralization and 
hallucinations [10-12], this relationship was not found for global gray or white matter asymmetry in the 
present study. On the other hand, we found global gray matter asymmetry to be negatively associated 
with anxiety and positively associated with negative symptomatology. Further analyses showed that the 
specific negative symptom responsible for this association was avolition, which some authors have 
proposed as the core of the negative symptoms [32]. There were no significant global gray matter 
asymmetry differences between patients with schizophrenia scoring high on anxiety and healthy control 
participants, whereas patients scoring low on anxiety had more asymmetric global gray matter than 
controls at a trend level of significance. Conversely, patients with schizophrenia presenting avolition had 
significantly more asymmetric global gray matter than healthy controls, whereas patients without 
avolition were as symmetric as controls. Although in Study II we did not have anxiety data, we tried to 
replicate the association between avolition and global gray matter asymmetry. The large sample used in 
this study permitted us to split the sample of patients into three categories according to their avolition 
score. The analyses showed that patients with the highest level of avolition had significantly more 
asymmetric global gray matter than those without symptoms of avolition or with low avolition 
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symptoms. Taken together, these results suggest a strong relationship between avolition and gray 
matter asymmetry. In addition, results also suggest that anxiety and avolition are opposite in terms of 
gray matter asymmetry, although this has yet to be replicated in larger samples. Attending to the 
characterization of both clinical symptoms, this may not be surprising. While anxiety implies anticipatory 
changes in response to an uncertain potential future threat [33], avolition is defined as a lack of 
motivation and a decrease in goal-directed behaviors [32]. That is, anxiety can be seen as an extreme 
worry for the future, whereas avolition indicates a lack of interest in the future, thus representing the 
opposite ends of a continuum. Moreover, avolition has been associated with reduced prefrontal 
activation [34] and bilateral frontal volume reduction [35], while anxiety has been associated with 
prefrontal hyperactivation [36]. Our results in global gray matter asymmetry may be a reflection of the 
underlying brain activation. In this case, patients with anxiety symptoms may have an abnormal increase 
in the gray matter symmetry of the prefrontal cortex, which would presumably represent an excess of 
prefrontal functioning. This hypothetical gray matter symmetry increase in the prefrontal cortex would 
also explain why patients with anxiety symptoms show similar gray matter Dice coefficients as healthy 
control participants. Consistent with our findings, other studies have found anxiety and depression, 
which might be related to avolition, to have opposite effects on brain activation during an object 
perception task [14]. Overall, these results suggest that anxiety and avolition may be partly explained by 
differences in global gray matter asymmetry, and they underline the importance of considering not only 
the negative but also the affective symptoms in the pathology of schizophrenia [37, 38]. 
 
There are some important open questions that future studies may address. First of all, it would be 
interesting to replicate these analyses in samples of first-episode schizophrenia patients or patients in 
high risk of psychosis. Such studies would clarify whether asymmetry differences between patients and 
controls are present before the illness onset, therefore strengthening the neurodevelopmental 
hypothesis, or whether these differences appear later and are due to the illness itself. Secondly, age and 
sex had important effects in all the analyses performed on gray matter asymmetry in Study II. Although 
the effects of age and sex on brain asymmetry have been previously assessed [26], a deeper analysis of 
these variables with the measure based on the Dice coefficient presented here might be of interest for 
future studies. Moreover, it has to be taken into account that brain development can stretch on until 
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the twenties and that the changes in gray and white matter are not linear [39], overall representing a 
major challenge that may be faced by studying brain asymmetry in different age groups.  
 
Finally, there were some limitations that should be mentioned. First, information regarding verbal IQ 
and education level could not be analyzed in Study II. Moreover, scores of anxiety symptoms were not 
available for the participants of Study II, making it impossible to replicate results on anxiety from Study I 
and leaving an unresolved question that future studies may also address. Lastly, since no information 
was available regarding psychiatric medication of the participants, its potential effects on gray and white 
matter could not be evaluated. 
 
In conclusion, we have used the Dice coefficient as a measure of global cerebral asymmetry for the first 
time. We showed that patients with schizophrenia have more globally asymmetric gray matter than 
controls. Findings from the present study suggest that global gray matter asymmetry could be a useful 
measure of fluctuating asymmetry and a tool to easily detect possible neurodevelopmental 
abnormalities. 
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Table 1. Global gray matter comparison between patients and controls from Study I. 
ANCOVA analyses of the Dice coefficient scores between patients with schizophrenia and healthy 
controls from Study I. Higher Dice scores indicate a lower degree of asymmetry. Verbal IQ and/or 
education level were included as covariates when they were significantly different between the 
corresponding subsample of patients and the healthy controls. Observed mean (SD) values are reported. 
 
 Patients with schizophrenia 
Healthy control 
participants 
(n=26) 
ANCOVA 
 Mean SD Mean SD F test df p ηp2 
GENERAL 
All patients (n=24) 0.8196 0.010 0.8263 0.008 4.36 1, 46 .042 .07 
ANXIETY 
Patients with anxiety (n=12) 0.8221 0.011 0.8263 0.008 1.95 1, 36 .171 .05 
Patients without anxiety (n=12) 0.8172 0.01 0.8263 0.008 3.81 1, 35 .059 .09 
AVOLITION 
Patients with avolition (n=7) 0.8143 0.008 0.8263 0.008 13.03 1, 31 .001 .30 
Patients without avolition 
(n=17) 0.8218 0.011 0.8263 0.008 1.52 1, 39 .226 .03 
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Figure 1. A comparison is shown of A) a patient with one of the lowest Dice scores (i.e., one of the most 
asymmetric participants, with a Dice score of 0.7902), and B) a healthy control with one of the highest 
Dice scores (i.e., one of the most symmetric participants, with a Dice score of 0.8435). Multiple axial 
slices, as well as a 3D view of the brain, are depicted. Both participants are 23 year-old females that 
were selected from the same database. Therefore, differences are not due to age, sex, or study. Only 
those regions with a Dice score greater than 0.5 are showed. It can be visually noted that the participant 
with the highest Dice score (B) has a larger proportion of her brain colored than the participant with the 
lowest Dice score (A). See section 1.5 of Study I for further details. 
 
Figure 2. Comparison of the Dice coefficient scores for global gray matter, from Study I, between 
healthy control participants ('HC', n = 26) and all the patients with schizophrenia ('SCH', n = 24) (left side 
of the chart), patients with avolition ('SCH / Avol +', n = 7) and without avolition ('SCH / Avol -', n = 17) 
(middle), and patients without anxiety ('SCH / Anx -', n = 12) and with anxiety ('SCH / Anx +', n = 12) 
(right). Differences in global gray matter asymmetry between healthy control participants and all the 
patients were significant (p = .042), as were differences between patients with avolition and healthy 
control participants (p = .001). The difference between the patients without anxiety and healthy control 
participants showed a trend towards significance (p = .059). On the other hand, patients without 
avolition and patients with anxiety did not have more asymmetric global gray matter than healthy 
control participants. The crosses represent all the individual observations, for each category, of the Dice 
scores for global gray matter asymmetry. The circles represent the estimated mean of the Dice scores 
for global gray matter asymmetry after covarying for verbal IQ and education, when necessary (see 
section 1.6 of Study I for more information). Error bars represent the standard error of the mean. See 
Table 1 and sections 2.1 and 2.2 of Study I in the text for further details. 
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Figure 3. Comparison of the Dice coefficient scores of global gray matter, from Study II, between healthy 
control participants ('HC', n = 404) and all the patients with schizophrenia ('SCH', n = 355) (left side of 
the chart), as well as between patients without avolition ('SCH / No avol', n = 142), patients with low 
avolition ('SCH / Low avol', n = 156), and patients with high avolition ('SCH / High avol', n = 57) (right). 
Differences in global gray matter asymmetry between healthy control participants and all the patients 
were significant (p < .001). Patients with high avolition had significantly more asymmetric global gray 
matter than patients without avolition (p = .018) and patients with low avolition (p = .050). All the 
avolition groups had significantly more global gray matter asymmetry than the group of healthy 
controls. The circles represent the estimated means of the Dice score for global gray matter asymmetry 
after covarying for age, sex, and database number, when necessary (see section 1.4 of Study II for more 
information). Error bars represent the standard error of the mean. See sections 2.1 and 2.2 of Study II in 
the text for further details. 
 
Figure 4. Graphical representation of asymmetry differences between patients with schizophrenia and 
healthy control participants. A) multiple axial slices are depicted showing regions where patients with 
schizophrenia were more symmetric than healthy control participants (top) and where controls were 
more symmetric than patients (bottom). These differences were also depicted in B) a 3D view, and C) a 
coronal section, in which the brain on the left side shows where patients were more symmetric than 
controls, and the brain on the right side shows where controls were more symmetric than patients. 
Composite group images for both patients with schizophrenia and healthy control participants were 
created from the individual Dice score images. These composite images were subtracted to each other 
to generate the images depicting inter-group asymmetry differences. All participants from Study I and 
Study II were included. For illustration purposes, we show only those regions with asymmetry 
differences larger than 25% of the maximum difference. 
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